CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 109 enrolled
Drug / intervention
Guanfacine +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00613015
NCT00613015Phase 2Completed
CompareCT.gov

Interdisciplinary Medication Development for Multiple Risk Factors in Relapse.

Medical University of South Carolina·interventional·Posted Feb 12, 2008·Updated Jun 4, 2018

In Brief

A Phase 2 clinical trial evaluating Guanfacine, Modafinil, and 1 other intervention for Cocaine Related Disorders. Completed, enrolled 109 participants across 1 site.

Detailed Summary

Stressful situations and cues associated with cocaine can lead to craving in cocaine dependent individuals. The purpose of this study is to determine whether guanfacine or modafinil are effective in reducing stress and cue induced craving in cocaine dependent individuals.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCocaine Related Disorders
CountriesUnited States
CollaboratorsNational Institute on Drug Abuse (NIDA)

Timeline

Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 12, 2008
Enrollment StartMay 1, 2008
Primary CompletionJul 1, 2012
TodayJul 2, 2026
Enrollment to primary: 4.2 yearsPosted 18.4 years ago

Interventions

Guanfacinedrug

Modafinildrug

Placebodrug